Fingerprint
Dive into the research topics of 'Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically